A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021)
Status:
Completed
Trial end date:
2014-10-29
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of 2 different dose levels of anacetrapib on low-density
lipoprotein-cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) in
participants with hypercholesterolemia when added to an existing statin-modifying therapy.